pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 3·1 min read
save

What it will take for more employer GLP-1 coverage

Last week, Eli Lilly proclaimed that its weight loss shot and pill are now “covered for millions of Americans,” now that all three major pharmacy benefit managers have put the ...

Jun 3, 2026·read at Endpoints ↗

June 3, 2026 11:24 AM EDT Health Tech What it will take for more em­ploy­er GLP-1 cov­er­age Shelby Livingston Health tech correspondent Last week, Eli Lil­ly pro­claimed that its weight loss shot and pill are now “cov­ered for mil­lions of Amer­i­cans,” now … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
77 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COLILLY
topics
GLP-1 receptor2Obesity2

related stories

  • Jun 30STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo NordiskSTAT
  • Jun 29STAT+: 26 states sue to block Medicaid work requirementsSTAT
  • Jun 18What’s next for GLP-1 weight loss drugs?STAT
  • Jun 11STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and moreSTAT
  • Jun 10AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicineBioPharma Dive